Fosamax and Fosamax Plus Tablets
ProPharma / PWR would like to bring to your attention a serious issue.
Both of the above mentioned products will have a PRICE DECREASE in the Pharmaceutical Schedule effective 1 January 2018.
Schedule price will move from $12.90 to $4.82
The communication of this change to the market has not been great but it is going to happen.
You need to ensure you dispense all your existing stock before 29 December 2017.
We cannot accept stock for credit in this situation.
We advise that we will reduce the price to pharmacy effective from Thursday 14th December 2017.
Our apologies for any inconvenience this may cause.